AVITA Medical, Inc.
AVITA Medical, Inc. (RCEL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RCEL · as of Jun 9, 2026
Key Statistics
Explore AVITA Medical, Inc. Data
rcel stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
The RCEL analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +92.31% upside from the current price of $4.16.
Competitors & Peers
rcel competitorsRCEL
APYX
FONR
HYPR
LUCD
NSPRStock Performance
Full HistoryAbout AVITA Medical, Inc.
AVITA Medical, Inc. is a leading company focused on regenerative tissue, actively commercializing its innovative products across the United States, Australia, and the United Kingdom. The company's mis…
what is avita medical, inc. · rcel stock overview · avita medical, inc. company profile · who is avita medical, inc. ceo · rcel NASDAQ · avita medical, inc. headquarters · avita medical, inc. business segments
About Stock Overview & Key Data
AVITA Medical, Inc. (RCEL) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since May 14, 2012. As of the latest trading session, RCEL stock price is $4.16, with a market capitalization of $103.3M. The stock has returned -31.91% over the past 12 months and +20.58% year-to-date.
According to 7 Wall Street analysts, the consensus rating for AVITA Medical, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, AVITA Medical, Inc. reported revenue of $71.6M and net income of -$48.6M. For detailed data — including AVITA Medical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AVITA Medical, Inc. (RCEL) stock price is $4.16. The stock is traded on NASDAQ under the ticker symbol RCEL. The 52-week range is $3.22 – $7.12.